ABSTRACT The effect of diethyl pyrocarbonate modification of histidine on the specific binding of [3H]diazepam and its enhancement with muscimol and (±)-pentobarbital was investigated. Diethyl pyrocarbonate treatment produced a dose-related inhibition of specific [3H]diazepam binding to rat brain membranes with a maximal inhibition of :40% at 1 mM. Scatchard analysis ofthe binding data showed that diethyl pyrocarbonate, while having no effect on the affmiity (kI), decreased the binding capacity (Bm..) of diazepam from a control value of 1543 ± 116 fmol/mg ofprotein to 789 ± 79 fmol/mg ofprotein (mean ± SD; P < 0.005; n = 4). Under conditions in which -40% of the diazepam binding sites were modified by diethyl pyrocarbonate treatment, the ability of muscimol and pentobarbital to enhance diazepam binding was not altered. These results suggest that a histidine residue is critical for a part ("40%) of the benzodiazepine binding sites and that there may exist a heterogeneity of benzodiazepine binding sites. Furthermore, these results indicate that perhaps only a portion of the benzodiazepine binding sites are functionally coupled to the y-aminobutyric acid receptor-ionophore complex.
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Benzodiazepine binding sites in the mammalian central nervous system have been characterized (1, 2) . Neurophysiological and biochemical (3) (4) (5) studies have shown that benzodiazepine binding sites are associated with the inhibitory neurotransmitter y-aminobutyric acid (GABA) receptor-ionophore complex. Binding of GABA to its receptor sites (6) (7) (8) and of a-dihydropicrotoxinin to possible GABA receptor-linked ionophores has also been characterized (9, 10) . The physiological postsynaptic response to GABA, both in mammalian motoneurons (11) and in crayfish muscle (12) , involves an increase in anion conductance that has a selectivity sequence of Br-> Cl-> I-. Benzodiazepines have been reported to potentiate the Cl--dependent GABA-mediated response (13) .
GABA agonists (3, 14) , barbiturates (14, 15) , and ethanol (16) have been reported to enhance [3H]diazepam binding to rat brain membranes. The ability of picrotoxin and bicuculline to prevent this enhancement suggests that the GABA receptor and ionophore components are involved in these actions (3, 14, 15) . Furthermore, anions, which permeate the ion channel at the spinal cord inhibitory synapse (17) , increase both basal diazepam binding (18) and the pentobarbital-induced increase (15) . These results suggest that the chloride-ionophore complex is critically associated with the benzodiazepine-GABA-receptor complex.
To understand the molecular pharmacology of benzodiazepines, it is essential not only to characterize the ligand binding but also to determine the functional groups that may directly or (14, 15) . Briefly, male Sprague-Dawley rats (150-200 g) were decapitated, and their brains (minus ponsmedulla) were rapidly removed and placed in buffer A (0.2 M sodium chloride/10 mM sodium phosphate, pH 7.0). The tissue was homogenized with a Brinkman Polytron twice, with 5-sec bursts. The homogenate was centrifuged at 1000 X g for 10 min, and the supernatant was then centrifuged at 140,000 X g for 45 min to obtain the mitochondrial plus microsomal (P2 + P3) fraction. The pellet was washed five times in buffer A by suspension and centrifugation and frozen overnight. On the following day, the pellet was thawed at room temperature, repelleted, washed once, and resuspended at a protein concentration ofO. 5 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. (Fig. 2) 20 ,M and that in Et2C205-treated preparation was 102 ± 15 ,uM (n = 4). Control of Et2C205-treated tissue was incubated with 1 nM [3Hldiazepam alone and in the presence of 100 ,uM (+)-pentobarbital.
Values represent mean ± SD of one experiment done in triplicate. These experiments were replicated five times with similar results. laxant, and sedative hypnotic. Benzodiazepines could mediate these effects by acting through a single or multiple receptor(s). Recent studies have shown that benzodiazepine binding sites are intimately associated with the GABA receptor-ionophore system (3) (4) (5) 18) . Benzodiazepines have been reported to potentiate GABA-mediated responses (4, 23) , and these effects are blocked by picrotoxin and bicuculline (4, 23) . Furthermore, GABA agonists (3, 14) , pentobarbital, (14, 15) , and ethanol (16) have been reported to increase the affinity of diazepam to its binding sites. The ability of anions (but not cations, including Na+) to enhance diazepam binding has led to the speculation that benzodiazepine sites are closely associated with the GABA receptor-regulated chloride ionophores (18) .
We have investigated the effect of histidine modification on diazepam binding and its enhancement by muscimol and pentobarbital. Histidine modification was carried out with Et2C205 at pH 6.0 and 0°C. Although Et2C205 reacts with many nucleophiles at pH >7.0, it is reasonably specific for the imidazole ring ofhistidine at pH 6.0, resulting in the formation ofN-ethyloxyformyl-histidine (20) (21) (22) . Our results indicate that histidine modification with Et2C205 results in a dose-dependent decrease in specific diazepam binding (Fig. 1) . This decrease is due to a reduction in the number of diazepam binding sites (Fig. 2) (25, 26) and to solubilized receptors (27, 28) . Furthermore, picrotoxinin prevents pentobarbital enhancement of diazepam binding (14, 15) . Et2C205-treatment has no effect on the binding of a-dihydropicrotoxinin (29) . Inability of Et2C2O5 treatment to alter pentobarbital enhancement of diazepam binding or to inhibit a-dihydropicrotoxinin binding is consistent with the finding that pentobarbital may act at the level of the picrotoxinin site at the benzodiazepine-GABA-receptor-ionophore complex. Neurophysiological observations also support this hypothesis (30) .
In summary, these results suggest that not all benzodiazepine receptors are functionally coupled to the GABA receptor-ionophore complex. At least two classes of benzodiazepine binding sites are suggested-one for which a histidine residue appears critical that is not coupled to the GABA receptor system and a second that is not modified by Et2C205 but is coupled.
